Publication
Article Metrics
Citations
Online attention
Fragment-derived selective inhibitors of dual-specificity kinases DYRK1A and DYRK1B
DOI:
10.1021/acs.jmedchem.1c00024
Authors:
David
Lee Walmsley
(Vernalis (R&D) Ltd)
,
James B.
Murray
(Vernalis (R&D) Ltd)
,
Pawel
Dokurno
(Vernalis (R&D) Ltd)
,
Andrew J.
Massey
(Vernalis (R&D) Ltd)
,
Karen
Benwell
(Vernalis (R&D) Ltd)
,
Andrea
Fiumana
(Vernalis (R&D) Ltd)
,
Nicolas
Foloppe
(Vernalis (R&D) Ltd)
,
Stuart
Ray
(Vernalis (R&D) Ltd)
,
Julia
Smith
(Vernalis (R&D) Ltd)
,
Allan E.
Surgenor
(Vernalis (R&D) Ltd)
,
Thomas
Edmonds
(Institut de Recherches Servier)
,
Didier
Demarles
(Technologie Servier)
,
Mike
Burbridge
(Institut de Recherches Servier)
,
Francisco
Cruzalegui
(Institut de Recherches Servier)
,
Andras
Kotschy
(Servier Research Institute of Medicinal Chemistry)
,
Roderick E.
Hubbard
(Vernalis (R&D) Ltd)
Co-authored by industrial partner:
Yes
Type:
Journal Paper
Journal:
Journal Of Medicinal Chemistry
State:
Published (Approved)
Published:
June 2021
Abstract: The serine/threonine kinase DYRK1A has been implicated in regulation of a variety of cellular processes associated with cancer progression, including cell cycle control, DNA damage repair, protection from apoptosis, cell differentiation, and metastasis. In addition, elevated-level DYRK1A activity has been associated with increased severity of symptoms in Down’s syndrome. A selective inhibitor of DYRK1A could therefore be of therapeutic benefit. We have used fragment and structure-based discovery methods to identify a highly selective, well-tolerated, brain-penetrant DYRK1A inhibitor which showed in vivo activity in a tumor model. The inhibitor provides a useful tool compound for further exploration of the effect of DYRK1A inhibition in models of disease.
Journal Keywords: Peptides and proteins; Crystal structure; Mixtures; Inhibition; Selectivity
Diamond Keywords: Down's Syndrome
Subject Areas:
Biology and Bio-materials,
Chemistry,
Medicine
Instruments:
I02-Macromolecular Crystallography
,
I03-Macromolecular Crystallography
,
I04-Macromolecular Crystallography
Added On:
30/06/2021 09:25
Discipline Tags:
Non-Communicable Diseases
Health & Wellbeing
Cancer
Biochemistry
Chemistry
Structural biology
Organic Chemistry
Drug Discovery
Life Sciences & Biotech
Technical Tags:
Diffraction
Macromolecular Crystallography (MX)